News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
A rising demand for biologics means that biotech companies face a multitude of manufacturing challenges, but also plenty of opportunities. We spoke to Kevin Sharp, senior VP and head of sales at Samsung Biologics, to examine what is driving this demand...
BioPharma Reporter and Outsourcing Pharma presents its latest round-up of the movers, shakers and key announcements in the pharma industry. From Stand Up To Cancer, Astraveus and KBI Biopharma, we break down the key changes.
Biotech company Cytomos has announced the creation of its newly named AuraCyt cell analysis technology brand and the launch of its improved website.